SARS-CoV-2 vaccines: Lights and shadows
Vaccines to prevent acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection elicit
an immune neutralizing response. Some concerns have been raised regarding the safety of
SARS-CoV-2 vaccines, largely based on case-reports of serious thromboembolic events
after vaccination. Some mechanisms have been suggested which might explain the adverse
cardiovascular reactions to SARS-CoV-2 vaccines. Different vaccine platforms are currently
available which include live attenuated vaccines, inactivated vaccines, recombinant protein …
an immune neutralizing response. Some concerns have been raised regarding the safety of
SARS-CoV-2 vaccines, largely based on case-reports of serious thromboembolic events
after vaccination. Some mechanisms have been suggested which might explain the adverse
cardiovascular reactions to SARS-CoV-2 vaccines. Different vaccine platforms are currently
available which include live attenuated vaccines, inactivated vaccines, recombinant protein …